Investment Partners Asset Management Inc. Buys 210 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Investment Partners Asset Management Inc. boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,132 shares of the exchange traded fund’s stock after purchasing an additional 210 shares during the quarter. Investment Partners Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $282,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Van ECK Associates Corp purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $1,497,000. Viewpoint Capital Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $180,000. Certuity LLC lifted its position in SPDR S&P Biotech ETF by 28.8% in the 4th quarter. Certuity LLC now owns 11,168 shares of the exchange traded fund’s stock worth $1,006,000 after buying an additional 2,494 shares during the last quarter. Weatherly Asset Management L. P. boosted its stake in SPDR S&P Biotech ETF by 0.3% in the fourth quarter. Weatherly Asset Management L. P. now owns 157,945 shares of the exchange traded fund’s stock worth $14,225,000 after buying an additional 532 shares in the last quarter. Finally, Kingsview Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 60.3% in the fourth quarter. Kingsview Wealth Management LLC now owns 6,350 shares of the exchange traded fund’s stock worth $572,000 after buying an additional 2,388 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $89.97 on Thursday. The company has a market capitalization of $6.86 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company’s 50 day moving average price is $92.05 and its two-hundred day moving average price is $96.25.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.